Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome
about
The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26IGF1R variants associated with isolated single suture craniosynostosisHeparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formationRegulatory variation at glypican-3 underlies a major growth QTL in miceThe Extracellular Matrix in Bronchopulmonary Dysplasia: Target and SourceGlypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinomaAdvances in liver cancer antibody therapies: a focus on glypican-3 and mesothelinDevelopment of the kidney medullaEstrogen-dependent proteolytic cleavage of semaphorin 4D and plexin-B1 enhances semaphorin 4D-induced apoptosis during postnatal vaginal remodeling in pubescent miceSpatiotemporal distribution of heparan sulfate epitopes during murine cartilage growth plate developmentOvergrowth of a mouse model of Simpson-Golabi-Behmel syndrome is partly mediated by Indian hedgehogGLI3 repressor controls nephron number via regulation of Wnt11 and Ret in ureteric tip cellsThe loss of glypican-3 induces alterations in Wnt signalingDally-like core protein and its mammalian homologues mediate stimulatory and inhibitory effects on Hedgehog signal responseIntegration of left-right Pitx2 transcription and Wnt signaling drives asymmetric gut morphogenesis via Daam2Loss of glypican-3 function causes growth factor-dependent defects in cardiac and coronary vascular developmentThe ureteric bud epithelium: morphogenesis and roles in metanephric kidney patterning.Angiotensin II regulates growth of the developing papillas ex vivoWnt signaling and renal medulla formation.GLI3 repressor controls functional development of the mouse ureterHeparan sulfate: lessons from knockout miceLiver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas.Novel MAPK-dependent and -independent tubulogenes identified via microarray analysis of 3D-cultured Madin-Darby canine kidney cellsLoss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in miceThe elusive functions of proteoglycans: in vivo veritasThe malformed kidney: disruption of glomerular and tubular development.Altering Glypican-1 levels modulates canonical Wnt signaling during trigeminal placode developmentEndostatin regulates branching morphogenesis of renal epithelial cells and ureteric bud.Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice.The life of the human kidney before birth: its secrets unfold.Glypicans: proteoglycans with a surprise.Ostreid herpesvirus type 1 replication and host response in adult Pacific oysters, Crassostrea gigas.The glypican 3-hosted murine mir717 gene: sequence conservation, seed region polymorphisms and putative targets.PLAC1 expression increases during trophoblast differentiation: evidence for regulatory interactions with the fibroblast growth factor-7 (FGF-7) axis.Glypican-3: a new target for cancer immunotherapy.Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling.The PLAC1 protein localizes to membranous compartments in the apical region of the syncytiotrophoblast.Simpson-Golabi-Behmel syndrome types I and II.Semaphorin 4D induces vaginal epithelial cell apoptosis to control mouse postnatal vaginal tissue remodelingβ-catenin causes renal dysplasia via upregulation of Tgfβ2 and Dkk1
P2860
Q24307887-12135631-A59D-472F-8D82-C07141156D26Q24594463-03167373-34E9-4628-99E1-2564663C84C0Q24650523-D8CF13B7-BD9E-4A5B-B69A-048A859A6C6CQ24806137-33F14ABE-EEC1-4BD6-8692-213BFB023396Q26771338-0B04974F-4A57-4315-92BD-34D9B0C375A3Q26772321-A531924F-2990-4650-8F83-3503D6F960D5Q27015134-674BC564-94BF-419E-9B88-03EDB84E100AQ27015938-7481D91B-2ECF-44A9-9F75-6A757AFC7748Q27330735-26CB6225-AEE8-481C-B360-56636D9226C6Q28251561-6B19BF9A-3471-4EC9-A8E1-85EC3F412577Q28509029-E5C6BDE1-87FD-4D74-8DC6-6E52714C2B4AQ28513713-01F9FED1-97EE-4EB5-A956-F98A908445A0Q28575434-43F80DF0-4AC3-472C-9C4A-07D5983ED912Q28583887-DE4FAA1D-2990-4446-BBB0-37E72A6F6148Q28586161-A1C09AA7-A4CC-4A44-B2C5-75EA77735312Q28587262-4BC7DF8C-D2E3-4EEA-8837-DBC00772C2F8Q30300352-3C5A045D-6DFA-478E-9293-6BAC10DCE9D0Q30419466-75020F94-15DD-4F65-B64A-15500DEA4D99Q30453346-4EB4ACE5-776F-481D-AE14-1BC45E84CB31Q30498339-DAB8DBDE-75C9-4AB6-B484-CD65523FA367Q30689506-0D6A19CB-0473-4AE7-924E-5110CC32635EQ33556193-D0641ED8-65EE-49CF-9634-AC5C56527D2FQ33568923-F9031713-189A-473F-962F-51574AFB5566Q33587338-D9FADB70-41C7-4F04-9573-7B40E8A48A21Q33825069-A303367E-EE07-4FC2-9E94-0FDA32CE7CFCQ33834682-E5FF84DE-8D16-4FB9-ACDA-A5F32ECCE744Q33849654-183DBA9B-023F-4AC5-8C2D-38F2DB44AFB5Q33947828-3EE721A8-ACAC-4BEE-BF31-0EC0F489D514Q34116157-EAB5F856-A7E5-48A0-8499-750A6D797F54Q34116465-499C9A3F-29DB-4B1B-AD4A-FA07D90A2B08Q34344168-E369D14A-7D4D-4358-AC8F-9F3BE1D28178Q34346271-07CAE0FB-F32C-4C67-AE6B-85367978B6C2Q34394783-2A087D57-D988-408E-9E7A-2A7B31F4FEC8Q34407986-628F7E71-919F-403E-A98C-DA846C438DD3Q34543102-321CC8AD-5512-4817-B0A0-EEBB0617C9DCQ34575866-CC157D59-A21C-4481-9161-9F2787E49EDFQ34594219-537A62EC-1AB9-464D-AAA5-B316D842E6F0Q34623852-EAAA2302-6291-4B6A-983F-478706206F84Q34673545-0F9BAA8F-D2AA-4C6E-8270-267D6A59828CQ34726881-897280C0-5506-4BCB-BC81-72D957FA270C
P2860
Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Glypican-3-deficient mice exhi ...... Simpson-Golabi-Behmel syndrome
@ast
Glypican-3-deficient mice exhi ...... Simpson-Golabi-Behmel syndrome
@en
Glypican-3-deficient mice exhi ...... Simpson-Golabi-Behmel syndrome
@nl
type
label
Glypican-3-deficient mice exhi ...... Simpson-Golabi-Behmel syndrome
@ast
Glypican-3-deficient mice exhi ...... Simpson-Golabi-Behmel syndrome
@en
Glypican-3-deficient mice exhi ...... Simpson-Golabi-Behmel syndrome
@nl
prefLabel
Glypican-3-deficient mice exhi ...... Simpson-Golabi-Behmel syndrome
@ast
Glypican-3-deficient mice exhi ...... Simpson-Golabi-Behmel syndrome
@en
Glypican-3-deficient mice exhi ...... Simpson-Golabi-Behmel syndrome
@nl
P2093
P2860
P3181
P356
P1476
Glypican-3-deficient mice exhi ...... Simpson-Golabi-Behmel syndrome
@en
P2093
A K Tanswell
D F Cano-Gauci
G A Lockwood
L Sedlackova
N D Rosenblum
P2860
P304
P3181
P356
10.1083/JCB.146.1.255
P407
P577
1999-07-01T00:00:00Z